Table S2 from A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity

Anti-proliferative activity of BR-cpd7 and BGJ398 in multiple human cancer cell lines. Human cancer cells were subjected to different concentrations of BR-cpd7 or BGJ398, and IC50 at 4 or 5 days was calculated (n=3 replicates).